机构：[1]The Institute of Hepatobiliary Surgery, Southwest Hospital, Army Medical University, Chongqing, China[2]Department of Liver Surgery, Peking Union Medical College (PUMC) Hospital, PUMC and Chinese Academy of Medical Sciences, Beijing, China[3]The Institute of Hepatobiliary Surgery, Xinqiao Hospital, Army Medical University, Chongqing, China[4]Department of Liver Surgery & Liver Transplantation Center, West China Hospital of Sichuan University, Chengdu, China四川大学华西医院[5]Department of Hepatobiliary Surgery, Anhui Provincial Hospital, Hefei, China[6]Department of Surgery, Ruijin Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China[7]Department of Hepatobiliary Surgery, The First Affiliated Hospital of Guangxi Medical University, Nanning, China[8]Department of Interventional Radiology, Zhongshan Hospital, Fudan University.Shanghai Institute of Medical Imaging, Shanghai, China[9]Department of Hepatobiliary Surgery, Lanzhou General Hospital of Lanzhou Military Area Command, PLA, Lanzhou, China
There is currently a lack of consensus regarding the clinical features, diagnosis, treatment indications and options, and risk assessment of hepatic hemangioma patients.This was a multicenter, real-world study that analyzed a large number of hepatic hemangioma cases in China and included patient data on epidemiology, diagnosis, treatment methods, and outcomes.A total of 5,143 patients hospitalized for hepatic hemangioma were included, of whom 34.42% were male and 65.58% were female. The age distribution was concentrated between 30 and 60 years old, accounting for 87.41% of the patients. Among the hepatic hemangioma patients, 60.8% had only one tumor, with the most common pathological type being cavernous hemangioma (96.07% of cases). The treatment motivations and indications included anxiety, obvious clinical symptoms, rapid tumor growth, unclear diagnoses and acute emergencies. Overall, 41.4% of the patients were treated for psychological reasons, while 30.59% were treated because they presented obvious (primarily nonspecific) clinical symptoms. Hepatic resection was the main therapeutic method and was based on various indications. There were a small number of patients with Kasabach-Merritt syndrome, according to its generally recognized definition.Most patients in this study who were hospitalized for hepatic hemangioma did not meet the indications for requiring treatment. Surveillance is the recommended course of action for definitively diagnosed hepatic hemangioma, and a new classification system is needed to standardize the diagnosis of this condition.2021 Annals of Translational Medicine. All rights reserved.
基金：
Social Livelihood Project Fund of Chongqing (201706-202005) (Project No. cstc2017shmsA0436) and the National Natural Science Foundation of China (Program No. 81773140).
第一作者机构：[1]The Institute of Hepatobiliary Surgery, Southwest Hospital, Army Medical University, Chongqing, China
共同第一作者：
通讯作者：
通讯机构：[1]The Institute of Hepatobiliary Surgery, Southwest Hospital, Army Medical University, Chongqing, China[*1]The Institute of Hepatobiliary Surgery, Southwest Hospital, 30 Gaotanyan Street, Sapingba District, Chongqing 400038, China.
推荐引用方式(GB/T 7714)：
Tang Tengqian,Wang Xishu,Mao Yilei,et al.Real-world data on the clinicopathological traits and outcomes of hospitalized liver hemangioma patients: a multicenter study.[J].ANNALS OF TRANSLATIONAL MEDICINE.2021,9(13):doi:10.21037/atm-20-4684.
APA：
Tang Tengqian,Wang Xishu,Mao Yilei,Li Jing,Wen Tianfu...&Xia Feng.(2021).Real-world data on the clinicopathological traits and outcomes of hospitalized liver hemangioma patients: a multicenter study..ANNALS OF TRANSLATIONAL MEDICINE,9,(13)
MLA：
Tang Tengqian,et al."Real-world data on the clinicopathological traits and outcomes of hospitalized liver hemangioma patients: a multicenter study.".ANNALS OF TRANSLATIONAL MEDICINE 9..13(2021)
